CAR is upregulated in SSc and regulates TGF-β signaling. Activation of CAR increases the profibrotic effects of TGF-β in cultured fibroblasts and in different preclinical models of SSc.
Thus, inactivation of CAR might be a novel approach to target aberrant TGF-β signaling in SSc and in other fibrotic diseases